United Kingdom

Ludwig Burger

Nordex close to selling European development pipeline to RWE

31 Jul 2020

FRANKFURT German wind turbine maker Nordex SE is in exclusive talks with utility RWE to sell its European wind and photovoltaic project development pipeline for about 400 million euros (£359.9 million) to focus on other regions.  

AstraZeneca to be exempt from coronavirus vaccine liability claims in most countries

30 Jul 2020

AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters.

'So far, so good' on leading COVID vaccine, says AstraZeneca

30 Jul 2020

Britain's AstraZeneca said on Thursday that good data was coming in so far on its vaccine for COVID-19, already in large-scale human trials and widely seen as the front-runner in the race for a shot against the novel coronavirus.

GSK profit misses as vaccine sales disappoint, stockpiling eases

29 Jul 2020

Britain's GSK on Wednesday missed second-quarter profit estimates following reduced sales of its existing vaccines and as patients used up treatments stockpiled during coronavirus lockdowns that have eased.

BASF says dividends, asset values under review as pandemic bites

29 Jul 2020

FRANKFURT Germany's BASF said on Wednesday its dividend policy and the value of assets on its balance sheet might be revised given uncertainty caused by the coronavirus crisis, particularly in North America and Europe.

Germany's IDT warns against equipment price hike in scramble for COVID-19 vaccine

28 Jul 2020

BERLIN/FRANKFURT A scramble to produce COVID-19 vaccines is pushing up prices for some bottling equipment and other raw materials, adding to industry concerns about limited output, a German vaccine maker told Reuters.

BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial

01 Jul 2020

FRANKFURT A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.

World News